Drugs / Jing-yan-kang Granule
last change Jun 2022 re-read 2 minutes ago

Jing-yan-kang Granule

Developed for
lung adenocarcinoma
Investigated by
Henan University of Traditional Chinese Medicine

Trials 1 · a red edge is where a trial was stopped

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT04482829 Sep → Dec 2020 lung adenocarcinoma Henan University of Traditional Chinese Medicine Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Jing-yan-kang Granule ClinicalTrials.gov intervention name — accepted as the source's own label NCT04482829